SCHEMBL8650792

SCHEMBL8650792

O=C(O)/C(=C/c1cccc(OCc2ccccc2)c1)c1cccnc1

nearest known ligand 0.78

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
LMNA P02545 2/20 0.69
THRB P10828 2/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
RAB9A P51151 1/20 0.55
KDM4E B2RXH2 1/20 0.52
PKM P14618 1/20 0.52
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
NR4A2 P43354 1/20 0.51
GPR132 Q9UNW8 6/20 0.50
CMKLR2 P46091 1/20 0.50
CMKLR1 Q99788 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8650796 1.00 ALDH1A1 (0.69) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL14021666 0.88 MEN1 (0.84) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL8645546 0.85 ALDH1A1 (0.59) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL8643121 0.85 ALDH1A1 (0.59) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL8643115 0.85 ALDH1A1 (0.59) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL27554954 0.83 ALDH1A1 (0.64) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL8645503 0.82 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8645501 0.82 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8649361 0.82 KMT2A (0.50) ALDH1A1LMNATHRBSMN1; SMN2MEN1
SCHEMBL8649367 0.82 KMT2A (0.50) ALDH1A1LMNATHRBSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861831-A1 HETEROARYL-SUBSTITUTED ACRYLOYLGUANIDINE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1998-09-02 EP disclosed